Enhanced Pre- and Post-natal Development (ePPND) study design evaluates all the stages of the traditional two study design (SEG II and SEG III) while using fewer animals.  Additionally, the ePPND study design provides an evaluation of the functional consequences of mid to late gestational exposure, something of particular value when assessing risk in monoclonal antibodies.

Contact us today to learn more about this exciting new reproductive and developmental toxicology study design.


Download a scientific poster on the following topic: